Primer: the practical use of biological markers of rheumatic and systemic inflammatory diseases.

作者: Eric Dayer , Jean-Michel Dayer , Pascale Roux-Lombard

DOI: 10.1038/NCPRHEUM0572

关键词:

摘要: Changes in the levels of serum components facilitate evaluation inflammatory reaction. In this article, use novel markers inflammation process, such as procalcitonin, ferritin and cytokines, classic markers, C-reactive protein, is reviewed. The assessment systemic by means laboratory tests often complements results medical examination. Traditionally, erythrocyte sedimentation rate leukocytosis with left shift are diagnostic for infectious diseases. acute-phase proteins—especially protein—are used to assess both presence any response treatment. determination protein may be advised three types pathological situation: infection, acute or chronic inflammation, metabolic risk. Procalcitonin useful a marker sepsis severe infection. concentration amyloid A predicts chances survival patients secondary (AA) amyloidosis. Ferritin its glycosylated form interest study specific diseases adult-onset Still's disease. Markers cartilage bone turnover complementary these inflammation. Although cytokine transiently crucial generation their usefulness clinic still under investigation. Serum concentrations inhibitors soluble receptors, well clinical treatment antagonists, might generate important information monitoring autoinflammatory

参考文章(61)
Cesare Perotti, Roberto Caporali, Carlomaurizio Montecucco, Lorenzo Cavagna, Eleonora Bruschi, Carlo Alberto Scirè, Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases. Clinical and Experimental Rheumatology. ,vol. 24, pp. 123- 128 ,(2006)
Jörg D. Seebach, Rudolf Morant, Regula Rüegg, Burkhardt Seifert, Jörg Fehr, The diagnostic value of the neutrophil left shift in predicting inflammatory and infectious disease. American Journal of Clinical Pathology. ,vol. 107, pp. 582- 591 ,(1997) , 10.1093/AJCP/107.5.582
Gabay C, N Cakir, F Moral, P Roux-Lombard, O Meyer, JM Dayer, T Vischer, H Yazici, PA Guerne, None, Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity. The Journal of Rheumatology. ,vol. 24, pp. 303- 308 ,(1997)
Jisoo Lee, Yong Beom Park, Soo Kon Lee, Chang Hee Suh, Won Ki Lee, Choong Won Lee, Chan Hee Lee, Chang Ho Song, Lipid profiles in untreated patients with rheumatoid arthritis. The Journal of Rheumatology. ,vol. 26, pp. 1701- 1704 ,(1999)
J M Dayer, J W Lowenthal, K Williamson, H R MacDonald, P Seckinger, A urine inhibitor of interleukin 1 activity that blocks ligand binding. Journal of Immunology. ,vol. 139, pp. 1546- 1549 ,(1987)
Dick Heinegård, Bengt Månsson, Tore Saxne, Biomarkers for cartilage and bone in rheumatoid arthritis Rheumatoid Arthritis: The New Frontiers in Pathogenesis and Treatment, 2nd edition; pp 301-301 (2006). pp. 301- 301 ,(2006)
Burkhard Möller, Peter M. Villiger, Inhibition of IL-1, IL-6, and TNF-α in immune-mediated inflammatory diseases Springer Seminars in Immunopathology. ,vol. 27, pp. 391- 408 ,(2006) , 10.1007/S00281-006-0012-9
Patrick Garnero, Biochemical markers in osteoarthritis: will they measure up? Nature Reviews Rheumatology. ,vol. 2, pp. 116- 117 ,(2006) , 10.1038/NCPRHEUM0132
SIMON A. JONES, SANKICHI HORIUCHI, NICHOLAS TOPLEY, NAOKI YAMAMOTO, GERALD M. FULLER, The soluble interleukin 6 receptor: mechanisms of production and implications in disease The FASEB Journal. ,vol. 15, pp. 43- 58 ,(2001) , 10.1096/FJ.99-1003REV